Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
48 participants
OBSERVATIONAL
2009-10-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal
Normal results from clinical exam and free of ocular pathology.
No interventions assigned to this group
Retina
Clinical exam results consistent with retina pathology
No interventions assigned to this group
Glaucoma
Clinical exam results consistent with glaucoma and visual field defects consistent with glaucoma.
No interventions assigned to this group
Cornea
Clinical exam results consistent with cornea pathology.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Glaucoma: Clinical exam results consistent with glaucoma and visual field defects consistent with glaucoma.
* Cornea: Clinical exam results consistent with cornea pathology.
* Retina: Clinical exam results consistent with retina pathology
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Optovue
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Optovue
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Hee, MD
Role: PRINCIPAL_INVESTIGATOR
Pacific Eye Specialists
Nalin Mehta, MD
Role: PRINCIPAL_INVESTIGATOR
Colorado Retina Center
Michael Sinai, PhD
Role: STUDY_DIRECTOR
Optovue
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pacific Eye Specialists
Daly City, California, United States
Colorado Retina Center
Denver, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
iVue 100-2009
Identifier Type: -
Identifier Source: org_study_id